<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Nevus sebaceus and nevus sebaceus syndromes
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Nevus sebaceus and nevus sebaceus syndromes
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Nevus sebaceus and nevus sebaceus syndromes
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Teresa S Wright, MD, FAAD, FAAP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Moise L Levy, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rosamaria Corona, MD, DSc
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 22, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H512656472">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nevus sebaceus, also called nevus sebaceus of Jadassohn or organoid nevus, is a benign hamartoma of the skin, characterized by hyperplasia of the epidermis, immature hair follicles, and sebaceous and apocrine glands. Lesions are usually present at birth and appear as waxy, yellow-orange or tan, hairless plaques  (
         <a class="graphic graphic_picture graphicRef89878" href="/z/d/graphic/89878.html" rel="external">
          picture 2C
         </a>
         ). They have a tendency to thicken and become more verrucous over time, especially around the time of puberty [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Nevus sebaceus and the nevus sebaceus syndrome, also called Schimmelpenning syndrome, will be reviewed in this topic. The linear epidermal nevus and epidermal nevus syndrome are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/13728.html" rel="external">
          "Epidermal nevus and epidermal nevus syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1937476883">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nevus sebaceus occurs in approximately 0.3 percent of newborns, without sex predilection. It is usually sporadic, but familial cases have been reported [
         <a href="#rid2">
          2,3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1314978913">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nevus sebaceus and nevus sebaceus syndrome (Schimmelpenning syndrome) are thought to be caused by postzygotic mosaic mutations in the
         <em>
          HRAS
         </em>
         or
         <em>
          KRAS
         </em>
         genes [
         <a href="#rid4">
          4
         </a>
         ], although isolated cases due to mosaic mutations in
         <em>
          NRAS
         </em>
         and
         <em>
          FGFR2
         </em>
         have also been reported [
         <a href="#rid5">
          5,6
         </a>
         ]. Along with phacomatosis pigmentokeratotica (PPK), cutaneous skeletal hypophosphatemia syndrome (CSHS), keratinocytic epidermal nevi, and some melanocytic nevi, they are included in the group of the so-called mosaic RASopathies [
         <a href="#rid7">
          7,8
         </a>
         ]. (See
         <a class="local">
          'Phacomatosis pigmentokeratotica'
         </a>
         below.)
        </p>
        <p>
         <em>
          RAS
         </em>
         promotes cell growth through activation of multiple pathways, including the mitogen-activated protein kinase (MAPK) signal-transduction pathway. Activating germline mutations in this gene family are involved in the pathogenesis of several inherited malformation syndromes (eg, Costello syndrome, Noonan syndrome, neurofibromatosis 1, Legius syndrome), some of which are associated with an increased risk of cancer. (See
         <a class="medical medical_review" href="/z/d/html/5832.html" rel="external">
          "Causes of short stature", section on 'Noonan syndrome'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2939.html" rel="external">
          "Neurofibromatosis type 1 (NF1): Pathogenesis, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
         An analysis of tissue samples from 65 individuals with nevus sebaceus and two with Schimmelpenning syndrome found an
         <em>
          HRAS
         </em>
         c.37G&gt;C mutation in 59 sebaceous nevi (91 percent) but not in the adjacent normal epidermis [
         <a href="#rid4">
          4
         </a>
         ]. An
         <em>
          HRAS
         </em>
         c.37G&gt;C mutation and a
         <em>
          KRAS
         </em>
         c.35G&gt;A mutation were found in lesional tissue samples from the two patients with nevus sebaceus syndrome. In another study, an
         <em>
          HRAS
         </em>
         c.37G&gt;C mutation was found in a patient with Schimmelpenning syndrome and in 24 of 31 isolated sebaceous nevi but in none of six patient-matched normal skin samples [
         <a href="#rid9">
          9
         </a>
         ]. In a whole-exome sequencing study of paired DNA from blood and sebaceous nevus tissue from five individuals with nevus sebaceus, recurrent somatic mutations in
         <em>
          HRAS
         </em>
         (p.Gly13Arg) and
         <em>
          KRAS
         </em>
         (p.Gly12Asp and p.Gly12Val) were identified in the epidermis and sebaceous lobules but not in the dermis or blood [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
         Taken together, these findings support the hypothesis that mosaic genetic mutations in the
         <em>
          HRAS
         </em>
         and
         <em>
          KRAS
         </em>
         genes are involved in the pathogenesis of nevus sebaceus. Extensive mosaicism for activating mutations involving the skin and skeletal, ocular, and central nervous systems may be the underlying genetic cause of Schimmelpenning syndrome [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H78683431">
         <span class="h1">
          HISTOPATHOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         In nevus sebaceus, the epidermis shows varying degrees of acanthosis and papillomatosis  (
         <a class="graphic graphic_picture graphicRef90270" href="/z/d/graphic/90270.html" rel="external">
          picture 1
         </a>
         ) [
         <a href="#rid12">
          12,13
         </a>
         ]. In early lesions, sebaceous glands may be underdeveloped and decreased in number. The presence of immature hair follicles is characteristic and diagnostic. After puberty, the epidermis shows prominent papillomatous hyperplasia. Sebaceous glands are abundant and sometimes situated at an abnormally high level in the dermis. Ectopic apocrine glands can be seen in most lesions, sometimes deep in the dermis, beneath the sebaceous glands.
        </p>
        <p class="headingAnchor" id="H78683438">
         <span class="h1">
          CLINICAL FEATURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         In most cases, nevus sebaceus is apparent at birth and presents as a well-defined, thin, yellow-orange or tan, oval, round, or linear plaque  (
         <a class="graphic graphic_picture graphicRef89876" href="/z/d/graphic/89876.html" rel="external">
          picture 2A
         </a>
         ). Sometimes lesions are not noticed until later in childhood or after puberty. Most commonly, nevus sebaceus occurs on the scalp and is associated with a well-defined, localized area of alopecia  (
         <a class="graphic graphic_picture graphicRef89878" href="/z/d/graphic/89878.html" rel="external">
          picture 2C
         </a>
         ). In older children and adults, lesions tend to be more elevated, verrucous, or nodular  (
         <a class="graphic graphic_picture graphicRef89876 graphicRef89877 graphicRef89878" href="/z/d/graphic/89876.html" rel="external">
          picture 2A-C
         </a>
         ) [
         <a href="#rid12">
          12
         </a>
         ]. The size ranges from one to several centimeters.
        </p>
        <p class="headingAnchor" id="H600927">
         <span class="h1">
          CLINICAL COURSE AND COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         In infancy and childhood, nevus sebaceus remains mostly unchanged, due to the quiescence of sebaceous glands. At puberty, under hormonal influences, lesions thicken and become verrucous or nodular  (
         <a class="graphic graphic_picture graphicRef90036 graphicRef90037" href="/z/d/graphic/90036.html" rel="external">
          picture 3A-B
         </a>
         ). Rapid, circumscribed enlargement or ulceration should arouse suspicion for malignant transformation. (See
         <a class="local">
          'Risk of malignancy'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H600933">
         <span class="h2">
          Risk of malignancy
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of benign and malignant epithelial neoplasms may arise within sebaceous nevi. Benign tumors include viral warts, trichoblastoma, syringocystadenoma papilliferum, tricholemmoma, sebaceoma, nodular hidradenoma, hidrocystoma, and eccrine poroma [
         <a href="#rid1">
          1,12-14
         </a>
         ]. Malignant neoplasms include basal cell carcinoma, apocrine carcinoma, trichilemmal carcinoma, sebaceous carcinoma, microcystic adnexal carcinoma, porocarcinoma, and squamous cell carcinoma. There are isolated reports of melanoma arising in a sebaceous nevus [
         <a href="#rid15">
          15,16
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13719.html" rel="external">
          "Microcystic adnexal carcinoma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/97893.html" rel="external">
          "Sebaceous carcinoma"
         </a>
         .)
        </p>
        <p>
         The exact incidence and the lifetime risk of malignancy arising in nevus sebaceus are unknown. In a review of nearly 5000 cases, benign and malignant tumors (mainly basal cell carcinomas) developed in 16 and 8 percent of patients, respectively [
         <a href="#rid17">
          17
         </a>
         ]. However, the incidence of basal cell carcinoma may have been overestimated, due to misinterpretation of trichoblastoma. Large case series published after 1990 report rates of basal cell carcinoma of &lt;1 percent [
         <a href="#rid18">
          18-20
         </a>
         ].
        </p>
        <p>
         The risk of malignancy increases with age, but basal cell carcinomas have also been reported in children. In a series of 631 patients, 5 (0.8 percent) had an associated basal cell carcinoma and 14 (2.2 percent) had a benign tumor [
         <a href="#rid20">
          20
         </a>
         ]. Four basal cell carcinomas occurred in children younger than 14 years.
        </p>
        <p>
         In another series of 706 patients aged 0 to 95 years, secondary neoplasms were found in 159 (22.5 percent) [
         <a href="#rid21">
          21
         </a>
         ]. In 19 percent of specimens, the associated lesion was a benign tumor (including trichoblastoma, syringocystadenoma papilliferum, apocrine/eccrine adenoma, and trichilemmoma). Eighteen specimens (2.5 percent) contained a malignant tumor, including eight basal cell carcinomas, four squamous cell carcinomas, and three sebaceous carcinomas. One case of apocrine carcinoma and one of microcystic adnexal carcinoma were also observed.
        </p>
        <p>
         In a series of 450 patients with nevus sebaceus, secondary tumors were found in 38 (8.5 percent) [
         <a href="#rid22">
          22
         </a>
         ]. Eighty percent of the tumors were benign, with syringocystadenoma papilliferum being the most common tumor (2.7 percent), followed by trichoblastoma (1.6 percent) and trichilemmoma (1.6 percent). Basal cell carcinoma was found in 0.9 percent of the cases.
        </p>
        <p>
         There are several reports of multiple different tumors arising simultaneously in the same sebaceous nevus [
         <a href="#rid23">
          23,24
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3043701223">
         <span class="h1">
          NEVUS SEBACEUS SYNDROMES
         </span>
        </p>
        <p class="headingAnchor" id="H3942155852">
         <span class="h2">
          Schimmelpenning syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Described for the first time in 1957, nevus sebaceus syndrome (MIM #163200; also called Schimmelpenning syndrome or Schimmelpenning-Feuerstein-Mims syndrome) is defined by the association of a linear nevus sebaceus, which is often extensive and distributed along the lines of Blaschko, with cerebral, ocular, or skeletal defects [
         <a href="#rid2">
          2,25
         </a>
         ].
        </p>
        <p>
         The syndrome is caused by an autosomal dominant, lethal mutation in
         <em>
          HRAS
         </em>
         or
         <em>
          KRAS
         </em>
         genes that survives by somatic mosaicism [
         <a href="#rid26">
          26
         </a>
         ]. Thus, all reported cases are sporadic.
        </p>
        <p>
         Involvement of the central nervous system is frequently associated with large sebaceous nevi located on the face or scalp. Neurologic abnormalities include developmental delay, seizures, and hemimegalencephaly [
         <a href="#rid27">
          27
         </a>
         ]. Ocular choristomas and colobomas are the most common ocular findings associated with nevus sebaceus syndrome [
         <a href="#rid28">
          28-30
         </a>
         ].
        </p>
        <p>
         Skeletal defects include craniofacial defects, hypoplastic bones, short stature, and vitamin D-resistant hypophosphatemic rickets [
         <a href="#rid31">
          31,32
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3657704661">
         <span class="h2">
          Phacomatosis pigmentokeratotica
         </span>
         <span class="headingEndMark">
          —
         </span>
         First described in 1996, phacomatosis pigmentokeratotica (PPK; also called phacomatosis spilosebacea) is an epidermal nevus syndrome characterized by the co-occurrence of a linear nevus sebaceus with a papular nevus spilus (also called speckled lentiginous nevus) [
         <a href="#rid33">
          33,34
         </a>
         ]. PPK is caused by postzygotic
         <em>
          HRAS
         </em>
         mutations in a multipotent progenitor cell that gives rise to both a sebaceous and a melanocytic nevus [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
         In neonates and infants, the presentation of a papular nevus spilus is that of a large café-au-lait macule, as the typical papular and macular speckles will develop later in life [
         <a href="#rid36">
          36
         </a>
         ]. Extracutaneous features are usually present, although rare cases without systemic involvement have been reported [
         <a href="#rid37">
          37,38
         </a>
         ]. They include neurologic (seizures, cognitive disability, hemiparesis, muscular weakness), ocular, musculoskeletal, endocrine, and vascular abnormalities [
         <a href="#rid36">
          36,39,40
         </a>
         ].
        </p>
        <p>
         Similarly to patients with Schimmelpenning syndrome, patients with PPK are predisposed to develop vitamin D-resistant hypophosphatemic rickets [
         <a href="#rid41">
          41,42
         </a>
         ]. Patients with PPK also have an increased risk of cutaneous and internal malignancies, including basal cell carcinoma, melanoma, rhabdomyosarcoma, and nephroblastoma [
         <a href="#rid43">
          43-45
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1620262741">
         <span class="h2">
          Cutaneous skeletal hypophosphatemia syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multisystem skin and bone disorder characterized by elevated circulating levels of fibroblast growth factor-23 (FGF23) [
         <a href="#rid8">
          8,46
         </a>
         ]. FGF23 is a 30kDa phosphatonin, a bone-derived hormone that regulates phosphorus homeostasis and vitamin D metabolism at the level of the renal proximal tubule cell [
         <a href="#rid46">
          46
         </a>
         ]. Patients present with widespread epidermal or melanocytic nevi and hypophosphatemic rickets. Somatic activating mutations in
         <em>
          HRAS
         </em>
         and
         <em>
          NRAS
         </em>
         have been found in both cutaneous lesions and dysplastic bone of patients with CSHS, suggesting that the syndrome is part of the mosaic RASopathy spectrum [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H78683472">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of nevus sebaceus is usually made clinically, based upon the finding of a circumscribed, slightly raised, yellow-orange plaque located on the scalp or face  (
         <a class="graphic graphic_picture graphicRef89878 graphicRef89876 graphicRef89877" href="/z/d/graphic/89878.html" rel="external">
          picture 2A-C
         </a>
         ). If the diagnosis is in question, a tissue biopsy should be performed for histologic confirmation. Typical histopathologic findings include immature hair follicles; hyperplastic, immature sebaceous glands; dilated apocrine glands; and epidermal hyperplasia [
         <a href="#rid13">
          13
         </a>
         ]. (See
         <a class="local">
          'Histopathology'
         </a>
         above.)
        </p>
        <p>
         No additional evaluation is needed for children presenting with a small, solitary nevus sebaceus. However, in patients with large or extensive lesions and suspected nevus sebaceus syndrome, a thorough neurologic and ophthalmologic examination should be performed. Additional evaluation is based upon clinical findings and may include electroencephalography, neuroimaging studies with magnetic resonance imaging (MRI), skeletal radiography, and analysis of liver and renal function, including urine calcium and phosphate levels [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H78683686">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of nevus sebaceus includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Aplasia cutis congenita
         </strong>
         – Aplasia cutis congenita is a focal absence of the skin. It typically presents with a sharply demarcated, ulcerated plaque or patch that may be covered by a tense epidermal membrane, giving the appearance of a fluid-filled bulla  (
         <a class="graphic graphic_picture graphicRef89935" href="/z/d/graphic/89935.html" rel="external">
          picture 4
         </a>
         ). The lesion usually reepithelializes over several months, resulting in a hypertrophic or atrophic scar. Rare instances of association of aplasia cutis congenita and sebaceous nevus in the same patient have been reported [
         <a href="#rid48">
          48,49
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13725.html" rel="external">
          "Aplasia cutis congenita"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Juvenile xanthogranuloma
         </strong>
         – Juvenile xanthogranuloma is a rare, benign, proliferative histiocytic disorder of dermal dendrocytes. It typically presents in infants as reddish to yellow papules, plaques, or nodules, most often on the head and neck and upper trunk  (
         <a class="graphic graphic_picture graphicRef68597 graphicRef69122" href="/z/d/graphic/68597.html" rel="external">
          picture 5A-B
         </a>
         ). Histology reveals a mixed dermal infiltrate of mononuclear cells, multinucleated giant cells with or without the features of Touton giant cells. (See
         <a class="medical medical_review" href="/z/d/html/13729.html" rel="external">
          "Juvenile xanthogranuloma (JXG)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidermal nevus
         </strong>
         –
         <strong>
         </strong>
         Epidermal nevi are benign hamartomas of the skin, presenting at birth or in the first year of life as linear plaques of skin-colored or brown, verrucous papules that follow the lines of Blaschko  (
         <a class="graphic graphic_picture graphicRef64855 graphicRef86582 graphicRef89783 graphicRef89782" href="/z/d/graphic/64855.html" rel="external">
          picture 6A-D
         </a>
         ). They are usually located on the trunk and limbs and are uncommon on the face  (
         <a class="graphic graphic_picture graphicRef89777" href="/z/d/graphic/89777.html" rel="external">
          picture 7
         </a>
         ) or scalp. Histology shows orthokeratotic hyperkeratosis and flat-topped papillary projections  (
         <a class="graphic graphic_picture graphicRef89244" href="/z/d/graphic/89244.html" rel="external">
          picture 8
         </a>
         ). On the head, epidermal (keratinocyte) nevi show linear or localized, woolly hair. (See
         <a class="medical medical_review" href="/z/d/html/13728.html" rel="external">
          "Epidermal nevus and epidermal nevus syndrome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Syringocystadenoma papilliferum
         </strong>
         – Syringocystadenoma papilliferum is a rare, benign adnexal tumor of infants and children. It presents as an asymptomatic, solitary, firm, pink papule or plaque most often located on the scalp  (
         <a class="graphic graphic_picture graphicRef89936" href="/z/d/graphic/89936.html" rel="external">
          picture 9
         </a>
         ). It may be seen alone or in association with other adnexal tumors, including nevus sebaceus. Histologic examination of the excised lesion shows epidermal cystic invaginations lined by papillae lined with a double layer of columnar epithelium, which shows an apocrine pattern of secretion  (
         <a class="graphic graphic_picture graphicRef89937" href="/z/d/graphic/89937.html" rel="external">
          picture 10
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/16910.html" rel="external">
          "Cutaneous adnexal tumors", section on 'Syringocystadenoma papilliferum'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Solitary mastocytoma
         </strong>
         – Cutaneous mastocytosis may present as a red, pink, or yellowish plaque or nodule in infancy or early childhood  (
         <a class="graphic graphic_picture graphicRef50284" href="/z/d/graphic/50284.html" rel="external">
          picture 11
         </a>
         ). The lesion tends to blister if rubbed, and rubbing may induce attacks of flushing. Nearly all solitary mastocytomas involute spontaneously in the first years of childhood. A skin biopsy may be necessary to confirm the clinical diagnosis. Histology reveals a large number of dermal mast cells in clusters or in a band-like pattern. (See
         <a class="medical medical_review" href="/z/d/html/4784.html" rel="external">
          "Mastocytosis (cutaneous and systemic) in adults: Epidemiology, pathogenesis, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nevus psiloliparus
         </strong>
         – Nevus psiloliparus is a type of mesodermal nevus occurring on the scalp and is characterized by the absence or paucity of hair and presence of an excessive amount of fatty tissue [
         <a href="#rid48">
          48
         </a>
         ]. It presents as a round or oval, soft alopecic patch located on one side of the parietal or frontoparietal area of the scalp. Histopathologic features include the absence or paucity of hair follicles and increased lipomatous or fibrolipomatous tissue. Nevus psiloliparus is the hallmark of encephalocraniocutaneous lipomatosis, a rare congenital neurocutaneous syndrome characterized by ocular anomalies, subcutaneous fatty masses, and intracranial and intraspinal lipomas [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         It may be difficult to differentiate among the various mosaic RASopathies, including the nevus sebaceus syndrome, epidermal nevus syndrome, phacomatosis pigmentokeratotica (PPK), and cutaneous skeletal hypophosphatemia syndrome (CSHS), due to considerable overlap in their cutaneous and extracutaneous features  (
         <a class="graphic graphic_table graphicRef114391" href="/z/d/graphic/114391.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H78683479">
         <span class="h1">
          MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The definitive treatment of nevus sebaceus is full-thickness excision. However, the necessity and timing of excision to prevent possible future malignancy are still debated [
         <a href="#rid17">
          17,19,20,51
         </a>
         ].
        </p>
        <p>
         The decision to excise the lesion should be made in individual patients, based upon age, extension and location of the lesion, and the patient's or parents/caregivers' concern about the cosmetic appearance and/or risk of malignancy. Since the risk of malignant transformation appears to be lower than previously believed, observation may be reasonable for lesions that do not cause cosmetic concern.
        </p>
        <p>
         Alternatives to surgical excision include photodynamic therapy, carbon dioxide laser resurfacing, and dermabrasion. However, since these treatment modalities do not completely remove the lesion, the risk of recurrence and potential for neoplasm development remains [
         <a href="#rid1">
          1,13
         </a>
         ].
        </p>
        <p>
         For children with Schimmelpenning syndrome and phacomatosis pigmentokeratotica (PPK), a multidisciplinary approach is needed, depending upon the type and extent of organ involvement, and may require the coordination of different specialists such as a dermatologist, pediatric neurologist, ophthalmologist, orthopedic surgeon, plastic surgeon, and psychologist [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H78683486">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition and pathogenesis
         </strong>
         – Nevus sebaceus is a rare, benign hamartoma of the skin, characterized by hyperplasia of the epidermis, immature hair follicles, and sebaceous and apocrine glands. Nevus sebaceous and the nevus sebaceous syndromes, including Schimmelpenning syndrome, phacomatosis pigmentokeratotica (PPK), and cutaneous skeletal hypophosphatemia syndrome (CSHS), are caused by postzygotic mosaic mutations in the
         <em>
          HRAS
         </em>
         or
         <em>
          KRAS
         </em>
         genes and are considered part of the so-called mosaic RASopathies. (See
         <a class="local">
          'Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – In most cases, nevus sebaceus is apparent at birth and presents as a well-defined, thin, yellow-orange or tan, linear plaque usually located on the scalp  (
         <a class="graphic graphic_picture graphicRef89878" href="/z/d/graphic/89878.html" rel="external">
          picture 2C
         </a>
         ). In older children and adults, lesions tend to be more elevated, verrucous, or nodular  (
         <a class="graphic graphic_picture graphicRef89876 graphicRef89877 graphicRef89878" href="/z/d/graphic/89876.html" rel="external">
          picture 2A-C
         </a>
         ). (See
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Schimmelpenning syndrome, one of the nevus sebaceus syndromes, is defined by the association of a nevus sebaceus with cerebral, ocular, or skeletal defects. (See
         <a class="local">
          'Schimmelpenning syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Associated tumors
         </strong>
         – A variety of benign and malignant epithelial neoplasms may arise within sebaceous nevi, including trichoblastoma, syringocystadenoma papilliferum, and basal cell carcinoma. (See
         <a class="local">
          'Risk of malignancy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of nevus sebaceus is usually based upon the clinical presentation. A biopsy for histopathologic confirmation may be warranted if the diagnosis is uncertain. For patients with suspected nevus sebaceus syndrome, a thorough neurologic and ophthalmologic examination should be performed. Additional evaluation includes electroencephalography, neuroimaging studies, and skeletal radiography. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
         – The definitive treatment of nevus sebaceus is full-thickness excision. The decision to excise should be made in individual patients, based upon age, extension and location of the lesion, and the patient's or parents/caregivers' concern about the cosmetic appearance and/or risk of malignancy. Since the risk of malignant transformation appears to be lower than previously believed, observation may be reasonable for lesions that do not cause cosmetic concern. (See
         <a class="local">
          'Management'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Eisen DB, Michael DJ. Sebaceous lesions and their associated syndromes: part I. J Am Acad Dermatol 2009; 61:549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Happle R, König A. Familial naevus sebaceus may be explained by paradominant transmission. Br J Dermatol 1999; 141:377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hughes SM, Wilkerson AE, Winfield HL, Hiatt KM. Familial nevus sebaceus in dizygotic male twins. J Am Acad Dermatol 2006; 54:S47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Groesser L, Herschberger E, Ruetten A, et al. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome. Nat Genet 2012; 44:783.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuroda Y, Ohashi I, Enomoto Y, et al. A postzygotic NRAS mutation in a patient with Schimmelpenning syndrome. Am J Med Genet A 2015; 167A:2223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuentz P, Fraitag S, Gonzales M, et al. Mosaic-activating FGFR2 mutation in two fetuses with papillomatous pedunculated sebaceous naevus. Br J Dermatol 2017; 176:204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luo S, Tsao H. Epidermal, sebaceous, and melanocytic nevoid proliferations are spectrums of mosaic RASopathies. J Invest Dermatol 2014; 134:2493.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lim YH, Ovejero D, Derrick KM, et al. Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy. J Am Acad Dermatol 2016; 75:420.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sun BK, Saggini A, Sarin KY, et al. Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome. J Invest Dermatol 2013; 133:824.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levinsohn JL, Tian LC, Boyden LM, et al. Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus. J Invest Dermatol 2013; 133:827.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Happle R. Nevus sebaceus is a mosaic RASopathy. J Invest Dermatol 2013; 133:597.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jaqueti G, Requena L, Sánchez Yus E. Trichoblastoma is the most common neoplasm developed in nevus sebaceus of Jadassohn: a clinicopathologic study of a series of 155 cases. Am J Dermatopathol 2000; 22:108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simi CM, Rajalakshmi T, Correa M. Clinicopathologic analysis of 21 cases of nevus sebaceus: a retrospective study. Indian J Dermatol Venereol Leprol 2008; 74:625.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiedemeyer K, Hartschuh W. Trichoblastomas with Merkel cell proliferation in nevi sebacei in Schimmelpenning-Feuerstein-Mims syndrome--histological differentiation between trichoblastomas and basal cell carcinomas. J Dtsch Dermatol Ges 2009; 7:612.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robinson AJ, Brown AP. Malignant melanoma arising in sebaceous naevus (of Jadassohn): a case report. J Plast Surg Hand Surg 2016; 50:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kimball KM, Craig E, Barrick C, Usmani A. Malignant Melanoma Arising in a Prolific Nevus Sebaceus With Colonization of Trichoblastoma. Am J Dermatopathol 2023; 45:196.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moody MN, Landau JM, Goldberg LH. Nevus sebaceous revisited. Pediatr Dermatol 2012; 29:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cribier B, Scrivener Y, Grosshans E. Tumors arising in nevus sebaceus: A study of 596 cases. J Am Acad Dermatol 2000; 42:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Santibanez-Gallerani A, Marshall D, Duarte AM, et al. Should nevus sebaceus of Jadassohn in children be excised? A study of 757 cases, and literature review. J Craniofac Surg 2003; 14:658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosen H, Schmidt B, Lam HP, et al. Management of nevus sebaceous and the risk of Basal cell carcinoma: an 18-year review. Pediatr Dermatol 2009; 26:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Idriss MH, Elston DM. Secondary neoplasms associated with nevus sebaceus of Jadassohn: a study of 707 cases. J Am Acad Dermatol 2014; 70:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hsu MC, Liau JY, Hong JL, et al. Secondary neoplasms arising from nevus sebaceus: A retrospective study of 450 cases in Taiwan. J Dermatol 2016; 43:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu Y, Valdebran M, Chen J, et al. Nevus Sebaceous of Jadassohn With Eight Secondary Tumors of Follicular, Sebaceous, and Sweat Gland Differentiation. Am J Dermatopathol 2016; 38:861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Namiki T, Miura K, Ueno M, et al. Four Different Tumors Arising in a Nevus Sebaceous. Case Rep Dermatol 2016; 8:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sugarman JL. Epidermal nevus syndromes. Semin Cutan Med Surg 2007; 26:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Happle R. Cutaneous manifestation of lethal genes. Hum Genet 1986; 72:280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davies D, Rogers M. Review of neurological manifestations in 196 patients with sebaceous naevi. Australas J Dermatol 2002; 43:20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trivedi N, Nehete G. Complex limbal choristoma in linear nevus sebaceous syndrome managed with scleral grafting. Indian J Ophthalmol 2016; 64:692.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nema N, Singh K, Verma A. Complex limbal choristoma in nevus sebaceous syndrome. Pediatr Dermatol 2012; 29:227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park JM, Kim DS, Kim J, et al. Epibulbar complex choristoma and hemimegalencephaly in linear sebaceous naevus syndrome. Clin Exp Dermatol 2009; 34:e686.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grebe TA, Rimsza ME, Richter SF, et al. Further delineation of the epidermal nevus syndrome: two cases with new findings and literature review. Am J Med Genet 1993; 47:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Narazaki R, Ihara K, Namba N, et al. Linear nevus sebaceous syndrome with hypophosphatemic rickets with elevated FGF-23. Pediatr Nephrol 2012; 27:861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Happle R, Hoffmann R, Restano L, et al. Phacomatosis pigmentokeratotica: a melanocytic-epidermal twin nevus syndrome. Am J Med Genet 1996; 65:363.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Torchia D, Happle R. Phacomatosis spilosebacea: A new name for a distinctive binary genodermatosis. J Am Acad Dermatol 2023; 89:764.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Groesser L, Herschberger E, Sagrera A, et al. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell. J Invest Dermatol 2013; 133:1998.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Happle R. The group of epidermal nevus syndromes Part I. Well defined phenotypes. J Am Acad Dermatol 2010; 63:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jennings L, Cummins R, Murphy GM, et al. HRAS mutation in phacomatosis pigmentokeratotica without extracutaneous disease. Clin Exp Dermatol 2017; 42:791.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chantorn R, Shwayder T. Phacomatosis pigmentokeratotica: a further case without extracutaneous anomalies and review of the condition. Pediatr Dermatol 2011; 28:715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin RJ, Arefi M, Splitt M, et al. Phacomatosis pigmentokeratotica and precocious puberty associated with HRAS mutation. Br J Dermatol 2018; 178:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tara A, Sada A, Inoue T, et al. A case of phacomatosis pigmentokeratotica in Japanese monozygotic twins. Acta Derm Venereol 2011; 91:602.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Morais OO, Costa LO, Shinzato DH, et al. Phacomatosis pigmentokeratotica--a patient with hypophosphatemic rickets. Skinmed 2013; 11:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bouthors J, Vantyghem MC, Manouvrier-Hanu S, et al. Phacomatosis pigmentokeratotica associated with hypophosphataemic rickets, pheochromocytoma and multiple basal cell carcinomas. Br J Dermatol 2006; 155:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martínez-Menchón T, Mahiques Santos L, Vilata Corell JJ, et al. Phacomatosis pigmentokeratotica: a 20-year follow-up with malignant degeneration of both nevus components. Pediatr Dermatol 2005; 22:44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Om A, Cathey SS, Gathings RM, et al. Phacomatosis Pigmentokeratotica: A Mosaic RASopathy with Malignant Potential. Pediatr Dermatol 2017; 34:352.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobelli S, Leclerc-Mercier S, Salomon R, et al. Phacomatosis pigmentokeratotica with nephroblastoma and juvenile hypertension. Acta Derm Venereol 2010; 90:279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lim YH, Ovejero D, Sugarman JS, et al. Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia. Hum Mol Genet 2014; 23:397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brandling-Bennett HA, Morel KD. Epidermal nevi. Pediatr Clin North Am 2010; 57:1177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Torrelo A, Boente Mdel C, Nieto O, et al. Nevus psiloliparus and aplasia cutis: a further possible example of didymosis. Pediatr Dermatol 2005; 22:206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tekin B, Yücelten AD, Akpınar IN, Ekinci G. Coexistence of aplasia cutis and nevus psiloliparus--report of a novel case. Pediatr Dermatol 2014; 31:746.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moog U. Encephalocraniocutaneous lipomatosis. J Med Genet 2009; 46:721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kong SH, Han SH, Kim JH, et al. Optimal Timing for Surgical Excision of Nevus Sebaceus on the Scalp: A Single-Center Experience. Dermatol Surg 2020; 46:20.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 13734 Version 15.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19751879" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Sebaceous lesions and their associated syndromes: part I.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10468835" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Familial naevus sebaceus may be explained by paradominant transmission.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16427992" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Familial nevus sebaceus in dizygotic male twins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22683711" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25914220" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : A postzygotic NRAS mutation in a patient with Schimmelpenning syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27095246" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Mosaic-activating FGFR2 mutation in two fetuses with papillomatous pedunculated sebaceous naevus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25219651" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Epidermal, sebaceous, and melanocytic nevoid proliferations are spectrums of mosaic RASopathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27444071" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23096709" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23096712" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23399824" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Nevus sebaceus is a mosaic RASopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10770429" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Trichoblastoma is the most common neoplasm developed in nevus sebaceus of Jadassohn: a clinicopathologic study of a series of 155 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19171988" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Clinicopathologic analysis of 21 cases of nevus sebaceus: a retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19192012" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Trichoblastomas with Merkel cell proliferation in nevi sebacei in Schimmelpenning-Feuerstein-Mims syndrome--histological differentiation between trichoblastomas and basal cell carcinomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26934428" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Malignant melanoma arising in sebaceous naevus (of Jadassohn): a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36729790" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Malignant Melanoma Arising in a Prolific Nevus Sebaceus With Colonization of Trichoblastoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21995782" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Nevus sebaceous revisited.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10642683" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Tumors arising in nevus sebaceus: A study of 596 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14501324" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Should nevus sebaceus of Jadassohn in children be excised? A study of 757 cases, and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19686305" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Management of nevus sebaceous and the risk of Basal cell carcinoma: an 18-year review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24268309" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Secondary neoplasms associated with nevus sebaceus of Jadassohn: a study of 707 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26361884" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Secondary neoplasms arising from nevus sebaceus: A retrospective study of 450 cases in Taiwan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27097338" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Nevus Sebaceous of Jadassohn With Eight Secondary Tumors of Follicular, Sebaceous, and Sweat Gland Differentiation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27194974" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Four Different Tumors Arising in a Nevus Sebaceous.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18395670" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Epidermal nevus syndromes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3957353" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Cutaneous manifestation of lethal genes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11869203" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Review of neurological manifestations in 196 patients with sebaceous naevi.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27853026" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Complex limbal choristoma in linear nevus sebaceous syndrome managed with scleral grafting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22329504" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Complex limbal choristoma in nevus sebaceous syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19583735" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Epibulbar complex choristoma and hemimegalencephaly in linear sebaceous naevus syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8368247" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Further delineation of the epidermal nevus syndrome: two cases with new findings and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22205508" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Linear nevus sebaceous syndrome with hypophosphatemic rickets with elevated FGF-23.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8923953" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Phacomatosis pigmentokeratotica: a melanocytic-epidermal twin nevus syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33583608" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Phacomatosis spilosebacea: A new name for a distinctive binary genodermatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23337891" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20542174" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : The group of epidermal nevus syndromes Part I. Well defined phenotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28736904" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : HRAS mutation in phacomatosis pigmentokeratotica without extracutaneous disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22082467" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Phacomatosis pigmentokeratotica: a further case without extracutaneous anomalies and review of the condition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28489335" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Phacomatosis pigmentokeratotica and precocious puberty associated with HRAS mutation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21597669" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : A case of phacomatosis pigmentokeratotica in Japanese monozygotic twins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23745233" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Phacomatosis pigmentokeratotica--a patient with hypophosphatemic rickets.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16792789" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Phacomatosis pigmentokeratotica associated with hypophosphataemic rickets, pheochromocytoma and multiple basal cell carcinomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15660897" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Phacomatosis pigmentokeratotica: a 20-year follow-up with malignant degeneration of both nevus components.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28523882" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Phacomatosis Pigmentokeratotica: A Mosaic RASopathy with Malignant Potential.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20526546" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Phacomatosis pigmentokeratotica with nephroblastoma and juvenile hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24006476" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20888465" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Epidermal nevi.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15916565" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Nevus psiloliparus and aplasia cutis: a further possible example of didymosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25424216" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Coexistence of aplasia cutis and nevus psiloliparus--report of a novel case.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19574261" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Encephalocraniocutaneous lipomatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30939520" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Optimal Timing for Surgical Excision of Nevus Sebaceus on the Scalp: A Single-Center Experience.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
